Sensible Biotechnologies
Unlocking the next generation of mRNA medicines
Marian Kupculak, Miroslav Gasparek · 2 co-founders
Profile coverage5 of 8 · missing Signals, Customers, Stack / tools · last run 8/10/2026
About
The future of mRNA therapeutics is hampered by manufacturing challenges and unless solved, its exciting potential may never be realised. Sensible enables the next generation of mRNA medicines by turning living cells into factories producing abundant, highly stable and non-immunogenic mRNA in a scalable and cost-effective way.